β-Agonists and asthma: too much of a good thing?
In an unusual paradox, asthmatics who are chronically treated with bronchodilating β-agonists sometimes experience a worsening of their condition. A new study describes one possible mechanism and reveals a potential new therapeutic target in the treatment of asthma.
Gardado en:
| Publicado en: | J Clin Invest |
|---|---|
| Principais autores: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Clinical Investigation
2003
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171402/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12925688/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19642 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|